Statistik Asas
| CIK | 1404123 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to 1life Healthcare Inc
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| March 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. (Exact name of registrant as specified in |
|
| February 22, 2023 |
Amended and Restated Bylaws of 1Life Healthcare, Inc. EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF 1LIFE HEALTHCARE, INC. Adopted on February 22, 2023 CONTENTS SECTION 1 OFFICES 1 SECTION 2 STOCKHOLDERS 1 2.1 Annual Meeting 1 2.2 Special Meetings 1 2.3 Place of Meeting 1 2.4 Notice of Meeting 1 2.5 Manner of Giving Notice; Affidavit of Notice 2 2.6 Waiver of Notice 2 2.7 Fixing of Record Date for Determining Stockholders 3 2.8 Voting List 4 2.9 |
|
| February 22, 2023 |
EX-4.1 Exhibit 4.1 Execution Version FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE, dated as of February 22, 2023 (this “Supplemental Indenture”), by and between 1Life Healthcare, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company (successor in interest to U.S. Bank National Association), National Association, as trustee (the “Trustee”), supplements th |
|
| February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 February 22, 2023 Date of Report (Date of earliest event reported) 1Life Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or other jurisdiction of incorporation or organizat |
|
| February 22, 2023 |
As filed with the U.S. Securities and Exchange Commission on February 21, 2023 As filed with the U.S. Securities and Exchange Commission on February 21, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 76-0707204 (State or other jurisdiction of Incorporation or organization) ( |
|
| February 22, 2023 |
As filed with the Securities and Exchange Commission on February 22, 2023 S-8 POS As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. |
|
| February 22, 2023 |
As filed with the Securities and Exchange Commission on February 22, 2023 S-8 POS As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. |
|
| February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2023 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 22, 2023 |
As filed with the Securities and Exchange Commission on February 22, 2023 S-8 POS As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. |
|
| February 22, 2023 |
As filed with the Securities and Exchange Commission on February 22, 2023 S-8 POS As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. |
|
| February 22, 2023 |
As filed with the Securities and Exchange Commission on February 22, 2023 POS AM As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. |
|
| February 22, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) 1Life Healthcare, Inc. |
|
| February 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39203 1LIFE HEALTHCAR |
|
| February 22, 2023 |
Exhibit 10.18 Certain information contained in this document, identified by [***], has been redacted because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed. THE FOLLOWING INFORMATION IS SUPPLIED SOLELY FOR U.S. FEDERAL INCOME TAX PURPOSES. BORROWINGS UNDER THE DDTL FACILITY WILL BE ISSUED WITH ORIGINAL ISSUE DISCOUNT (“OID”) WITHIN |
|
| February 22, 2023 |
One Medical Announces Results for Fourth Quarter and Full Year 2022 Exhibit 99.1 One Medical Announces Results for Fourth Quarter and Full Year 2022 •2022 Ending Total Membership Count of 836,000, a 14% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 796,000 and At-Risk Membership Count of 40,000 •Fourth Quarter 2022 Net Revenue of $274.2 Million, a 19% Increase Year-Over-Year •Full Year 2022 Net Revenue of $1.046 Billion, a 68% Increas |
|
| February 22, 2023 |
Amended and Restated Certificate of Incorporation of 1Life Healthcare, Inc. EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION of 1LIFE HEALTHCARE, INC. ARTICLE 1. NAME The name of this corporation is 1Life Healthcare, Inc. ARTICLE 2. REGISTERED OFFICE AND AGENT The address of the initial registered office of this corporation is 251 Little Falls Drive, Wilmington, County of New Castle, Delaware 19808-1674 and the name of its initial registered agent at s |
|
| February 22, 2023 |
Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a description of the common stock, $0.001 par value per share (“Common Stock”) of 1Life Healthcare, Inc. (the “Company,” “we,” “our,” or “us”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1 |
|
| February 22, 2023 |
As filed with the Securities and Exchange Commission on February 22, 2023 S-8 POS As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. |
|
| February 22, 2023 |
As filed with the Securities and Exchange Commission on February 22, 2023 POSASR As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. |
|
| February 22, 2023 |
List of Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of 1Life Healthcare Inc. Name Domestic Jurisdiction Iora Health, LLC (formerly Iora Health, Inc.) Delaware Iora Senior Health, LLC (formerly Iora Senior Health, Inc.) Delaware Iora Health NE DCE, LLC Delaware Iora Health Quality Network LLC Delaware OM Seniors, Inc. Delaware One Medical ACO, LLC Delaware PeakMed Colorado, LLC Colorado |
|
| February 14, 2023 |
ONEM / 1life Healthcare Inc / TIGER GLOBAL MANAGEMENT LLC Passive Investment SC 13G/A 1 d992946613g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* 1Life Healthcare, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 68269G107 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| February 10, 2023 |
ONEM / 1life Healthcare Inc / Temasek Holdings (Private) Ltd - SC 13G/A Passive Investment SC 13G/A 1 d428193dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* 1Life Healthcare, Inc. (Name of Issuer) Common Stock, $0.001 par value (Ti |
|
| February 9, 2023 |
ONEM / 1life Healthcare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0135-1lifehealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: 1Life Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 68269G107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to desi |
|
| November 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| November 2, 2022 |
One Medical Announces Results for Third Quarter 2022 Exhibit 99.1 One Medical Announces Results for Third Quarter 2022 ?Third Quarter 2022 Ending Total Membership Count of 815,000, a 14% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 775,000 and At-Risk Membership Count of 40,000 ?Third Quarter 2022 Net Revenue of $261.4 Million, a 73% Increase Year-Over-Year SAN FRANCISCO ? November 2, 2022 ? 1Life Healthcare, Inc. (One |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission |
|
| September 23, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2022 1LIFE HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-39203 76-0707204 (State or other jurisdiction of incorporation) (Commissi |
|
| September 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of |
|
| September 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incor |
|
| September 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2022 1LIFE HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-39203 76-0707204 (State or other jurisdiction of incorporation) (Commissio |
|
| September 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2022 1LIFE HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-39203 76-0707204 (State or other jurisdiction of incorporation) (Commissio |
|
| August 24, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi |
|
| August 10, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi |
|
| August 10, 2022 |
Exhibit 107 Calculation of Filing Fee Table SCHEDULE 14A (Form Type) 1Life Healthcare, Inc. |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| August 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| August 3, 2022 |
One Medical Announces Results for Second Quarter 2022 Exhibit 99.1 One Medical Announces Results for Second Quarter 2022 ?Second Quarter 2022 Ending Total Membership Count of 790,000, a 27% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 750,000 and At-Risk Membership Count of 40,000 ?Second Quarter 2022 Net Revenue of $255.8 Million, a 112% Increase Year-Over-Year SAN FRANCISCO ? August 3, 2022 ? 1Life Healthcare, Inc. (O |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| August 1, 2022 |
ONEM / 1life Healthcare Inc / FMR LLC Passive Investment SCHEDULE 13G Amendment No.6 1LIFE HEALTHCARE INC COMMON STOCK Cusip #68269G107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #68269G107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 4,307,089 Item 6: 0 Item 7: 4,311,107 Item 8: 0 Item 9: 4,311,107 Item 11: 2 |
|
| July 22, 2022 |
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER among AMAZON.COM, INC., NEGRONI MERGER SUB, INC. and 1LIFE HEALTHCARE, INC. Dated as of July 20, 2022 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 SECTION 1.01 The Merger 2 SECTION 1.02 Closing 2 SECTION 1.03 Effective Time 2 SECTION 1.04 Effects of the Merger 2 SECTION 1.05 Certificate of Incorporation and By-Laws of the Surviving Compan |
|
| July 22, 2022 |
Exhibit 99.1 Amazon and One Medical sign an agreement for Amazon to acquire One Medical One Medical is a human-centered, technology-powered U.S. primary care organization on a mission to make quality healthcare more affordable, accessible, and enjoyable through a seamless combination of in-person, digital, and virtual care services One Medical combines in-person care in inviting offices across the |
|
| July 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| July 22, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2022 1LIFE HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-39203 76-0707204 (State or other jurisdiction of incorporation) (Commission Fi |
|
| July 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2022 1LIFE HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-39203 76-0707204 (State or other jurisdiction of incorporation) (Commission Fi |
|
| July 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| June 6, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| May 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| May 4, 2022 |
One Medical Announces Results for First Quarter 2022 Exhibit 99.1 One Medical Announces Results for First Quarter 2022 ?First Quarter 2022 Ending Total Membership Count of 767,000, a 28% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 728,000 and At-Risk Membership Count of 39,000 ?First Quarter 2022 Net Revenue of $254.1 Million, a 109% Increase Year-Over-Year ?Ending First Quarter 2022 Cash and Marketable Securities of |
|
| May 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| April 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 21, 2022 |
DEFA14A 1 onem2022proxyadditionalmat.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of t |
|
| March 4, 2022 |
ONEM / 1life Healthcare Inc / Temasek Holdings (Private) Ltd - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* 1Life Healthcare, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 68269 |
|
| February 23, 2022 |
List of Subsidiaries of the Registrant Exhibit 21.1 Subsidiaries of 1Life Healthcare Inc. Name Domestic Jurisdiction Iora Health, Inc. Delaware Iora Senior Health, Inc. Delaware Iora Health NE DCE, LLC Delaware Iora Health Quality Network, LLC Delaware |
|
| February 23, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2022 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 23, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) 1Life Healthcare, Inc. |
|
| February 23, 2022 |
One Medical Announces Results for Fourth Quarter and Full Year 2021 Exhibit 99.1 One Medical Announces Results for Fourth Quarter and Full Year 2021 ?2021 Ending Total Membership Count of 736,000, a 34% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 703,000 and At-Risk Membership Count of 33,000 ?Fourth Quarter 2021 Net Revenue of $230.2 Million, an 89% Increase Year-Over-Year ?Full Year 2021 Net Revenue of $623.3 Million, a 64% Increa |
|
| February 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39203 1LIFE HEALTHCAR |
|
| February 23, 2022 |
Exhibit 4.3 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a description of the common stock, $0.001 par value per share (?Common Stock?) of 1Life Healthcare, Inc. (the ?Company,? ?we,? ?our,? or ?us?), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1 |
|
| February 23, 2022 |
As filed with the U.S. Securities and Exchange Commission on February 23, 2022 As filed with the U.S. Securities and Exchange Commission on February 23, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 76-0707204 (State or other jurisdiction of Incorporation or organization) ( |
|
| February 14, 2022 |
ONEM / 1life Healthcare Inc / TIGER GLOBAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
ONEM / 1life Healthcare Inc / Benchmark Capital Partners V L P - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. 1)* 1Life Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 68269G107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this |
|
| February 11, 2022 |
ONEM / 1life Healthcare Inc / Carlyle Group Inc. - SC 13G/A Passive Investment Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to ? 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to ? 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* 1Life Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 68269G107 ( |
|
| February 9, 2022 |
ONEM / 1life Healthcare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: 1Life Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 68269G107 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| November 3, 2021 |
One Medical Announces Results for Third Quarter 2021 Exhibit 99.1 One Medical Announces Results for Third Quarter 2021 ?Third Quarter 2021 Ending Total Membership Count of 715,000, a 40% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 683,000 and At-Risk Membership Count of 32,000 ?Third Quarter 2021 Net Revenue of $151.3 Million, a 49% Increase Year-Over-Year ?Ending Third Quarter 2021 Cash and Short-term Marketable Secu |
|
| November 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission |
|
| September 7, 2021 |
Iora Health, Inc. Third Amended and Restated 2011 Equity Incentive Plan. Exhibit 99.1 IORA Health Inc. THIRD AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN 1.DEFINED TERMS Exhibit A, which is incorporated by reference, defines the terms used in the Plan and sets forth certain operational rules related to those terms. 2.PURPOSE The Plan has been established to advance the interests of the Company by providing for the grant to Participants of Stock-based and other incen |
|
| September 7, 2021 |
As filed with the U.S. Securities and Exchange Commission on September 7, 2021 As filed with the U.S. Securities and Exchange Commission on September 7, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 76-0707204 (State or other jurisdiction of Incorporation or organization) ( |
|
| September 1, 2021 |
One Medical Completes Acquisition of Iora Health Exhibit 99.1 One Medical Completes Acquisition of Iora Health SAN FRANCISCO ? September 1, 2021 ? One Medical (1Life Healthcare, Inc., Nasdaq: ONEM), a leading human-centered and technology-powered national primary care organization, today announced it has completed the acquisition of Iora Health, a human-centered, value-based primary care organization with built-for-purpose technology focused on |
|
| September 1, 2021 |
One Medical Appoints Mary Ann Tocio to Board of Directors Exhibit 99.2 One Medical Appoints Mary Ann Tocio to Board of Directors SAN FRANCISCO, September 1, 2021 ? One Medical (NASDAQ: ONEM), a leading national technology-powered primary care organization, today announced the appointment of Mary Ann Tocio to its board of directors. Ms. Tocio is the former President and Chief Operating Officer of Bright Horizons Family Solutions, and joins the board with |
|
| September 1, 2021 |
1 + Transforming healthcare for all through a human-centered, technology-powered model at every stage of life September 2021 2 Forward-Looking Statements This presentation contains forward-looking statements which include, but are not limited to, statements regarding effects and anticipated benefits of the transaction between One Medical and Iora Health, Inc. |
|
| September 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| August 30, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission |
|
| August 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission |
|
| August 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission |
|
| August 6, 2021 |
Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| August 4, 2021 |
One Medical Announces Results for Second Quarter 2021 Exhibit 99.1 One Medical Announces Results for Second Quarter 2021 ?Second Quarter 2021 Ending Membership Count of 621,000, a 31% Increase Year-Over-Year ?Second Quarter 2021 Net Revenue of $120.4 Million, a 54% Increase Year-Over-Year ?Ending Second Quarter 2021 Cash and Short-term Marketable Securities of $653.8 Million ?Provides Q3 2021 Guidance and Updates Full Year 2021 Guidance SAN FRANCISCO |
|
| August 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| July 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| July 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| July 16, 2021 |
MERGER PROPOSAL—YOUR VOTE IS VERY IMPORTANT Table of Contents Filed pursuant to Rule 424(b)(3) Registration No. 333-257720 MERGER PROPOSAL?YOUR VOTE IS VERY IMPORTANT Dear stockholders of 1Life Healthcare, Inc. and stockholders of Iora Health, Inc.: As previously announced, the board of directors of 1Life Healthcare, Inc., which we refer to as the 1Life Board, and the board of directors of Iora Health, Inc., which we refer to as the Iora Bo |
|
| July 14, 2021 |
1Life Healthcare, Inc. One Embarcadero Center, Suite 1900 San Francisco, CA 94111 (415) 814-0927 CORRESP 1 filename1.htm 1Life Healthcare, Inc. One Embarcadero Center, Suite 1900 San Francisco, CA 94111 (415) 814-0927 July 14, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Margaret Schwartz Re: 1Life Healthcare, Inc. Registration Statement on Form S-4 (File No. 333-257720) Dear Ms. Schwartz: This |
|
| July 14, 2021 |
As filed with the Securities and Exchange Commission on July 14, 2021 Table of Contents As filed with the Securities and Exchange Commission on July 14, 2021 Registration No. |
|
| July 14, 2021 |
Form of Proxy Card for 1Life Healthcare, Inc. special meeting Exhibit 99.3 VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting in |
|
| July 14, 2021 |
Consent of Morgan Stanley & Co. LLC Exhibit 99.1 Consent of Morgan Stanley & Co. LLC We hereby consent to the use in the Amendment No. 1 to the Registration Statement of 1Life Healthcare, Inc. on Form S-4 (the ?Registration Statement?) and in the Proxy Statement/Prospectus/Consent Solicitation Statement of 1Life Healthcare, Inc. and Iora Health, Inc., which is part of the Registration Statement, of our written opinion, dated June 6, |
|
| July 14, 2021 |
Consent of Person Named as About to Become Director Exhibit 99.2 Consent of Person Named as About to Become Director 1Life Healthcare, Inc. (the ?Company?) has filed a Registration Statement on Form S-4 (as amended, the ?Registration Statement?) with the Securities and Exchange Commission under the Securities Act of 1933 (as amended, the ?Securities Act?) as of the date hereof. In connection therewith, I hereby consent, pursuant to Rule 438 of the |
|
| July 12, 2021 |
PEC Talking Points About the One Medical Announcement Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| July 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| July 12, 2021 |
Email to Alumni Equity Holders Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| July 6, 2021 |
Consent of Morgan Stanley & Co. LLC Exhibit 99.1 Consent of Morgan Stanley & Co. LLC We hereby consent to the use in the Registration Statement of 1Life Healthcare, Inc. on Form S-4 (the ?Registration Statement?) and in the Proxy Statement/Prospectus/Consent Solicitation Statement of 1Life Healthcare, Inc. and Iora Health, Inc., which is part of the Registration Statement, of our written opinion, dated June 6, 2021, appearing as Ann |
|
| July 6, 2021 |
Power of Attorney (included on signature page to the initial filing of this registration statement) Table of Contents As filed with the Securities and Exchange Commission on July 6, 2021 Registration No. |
|
| June 28, 2021 |
FAQs Posted on Canopy for all Employees Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| June 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| June 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| June 15, 2021 |
Equity Compensation Information for Iora Employees Related to One Medical Combination Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| June 9, 2021 |
Equity Compensation Information for Iora Employees Related to One Medical Combination Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| June 8, 2021 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among 1LIFE HEALTHCARE, INC., SB MERGER SUB, INC., IORA HEALTH, INC. and FORTIS ADVISORS LLC AS THE STOCKHOLDERS? REPRESENTATIVE Dated as of June 6, 2021 TABLE OF CONTENTS Page ARTICLE I THE MERGER Section 1.1 The Merger and Related Matters 2 Section 1.2 Effect on Capital Stock, Options, Company Phantom Stock Awards and Warrants 4 Section 1.3 Escrow Funds 7 |
|
| June 8, 2021 |
Transcript of Iora Town Hall Meeting Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| June 8, 2021 |
Form of One Medical Voting Agreement. Exhibit 10.2 VOTING AGREEMENT This Voting Agreement (this ?Agreement?) is entered into as of June , 2021, by and among Iora Health, Inc., a Delaware corporation (the ?Company?), 1Life Healthcare, Inc., a Delaware corporation (?Parent?), and the stockholder of Parent set forth on Exhibit A hereto (the ?Specified Stockholder?). Recitals A. The Specified Stockholder is a holder of record and the ?ben |
|
| June 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| June 8, 2021 |
Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc., a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. (?Merger S |
|
| June 8, 2021 |
One Medical Appoints Scott C. Taylor to Board of Directors Exhibit 99.1 One Medical Appoints Scott C. Taylor to Board of Directors San Francisco, June 8, 2021 - One Medical (NASDAQ: ONEM), a leading national technology-powered primary care organization, today announced the appointment of Scott C. Taylor to its board of directors. As the former Executive Vice President, General Counsel and Corporate Secretary of Symantec Corporation (now called NortonLifeL |
|
| June 8, 2021 |
Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) The following communication is being filed in connection with the acquisition of Iora Health, Inc. by 1Life Healthcare, Inc. 1 + Transformin |
|
| June 8, 2021 |
Iora’s Transaction-focused Canopy Page FAQs Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc. (?Iora?), a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. ( |
|
| June 8, 2021 |
Exhibit 10.1 JOINDER AND SUPPORT AGREEMENT This JOINDER AND SUPPORT AGREEMENT (this ?Agreement?), dated as of June , 2021, is made and entered into by and among 1Life Healthcare, Inc., a Delaware corporation (?Parent?), Iora Health, Inc., a Delaware corporation (the ?Company?) and the undersigned holder of Company Capital Stock (together with any of his, her or its Affiliates, the ?Holder?). Each |
|
| June 8, 2021 |
Filed by 1Life Healthcare, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Iora Health, Inc. (Commission File No. 001-39203) This filing relates to the proposed merger of Iora Health, Inc. (?Iora?), a Delaware Corporation (?Iora Health?), with SB Merger Sub, Inc. ( |
|
| June 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| June 7, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| June 7, 2021 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among 1LIFE HEALTHCARE, INC., SB MERGER SUB, INC., IORA HEALTH, INC. and FORTIS ADVISORS LLC AS THE STOCKHOLDERS? REPRESENTATIVE Dated as of June 6, 2021 TABLE OF CONTENTS Page ARTICLE I THE MERGER Section 1.1 The Merger and Related Matters 2 Section 1.2 Effect on Capital Stock, Options, Company Phantom Stock Awards and Warrants 4 Section 1.3 Escrow Funds 7 |
|
| June 7, 2021 |
Exhibit 10.2 VOTING AGREEMENT This Voting Agreement (this ?Agreement?) is entered into as of June , 2021, by and among Iora Health, Inc., a Delaware corporation (the ?Company?), 1Life Healthcare, Inc., a Delaware corporation (?Parent?), and the stockholder of Parent set forth on Exhibit A hereto (the ?Specified Stockholder?). Recitals A. The Specified Stockholder is a holder of record and the ?ben |
|
| June 7, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| June 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| June 7, 2021 |
Exhibit 10.1 JOINDER AND SUPPORT AGREEMENT This JOINDER AND SUPPORT AGREEMENT (this ?Agreement?), dated as of June , 2021, is made and entered into by and among 1Life Healthcare, Inc., a Delaware corporation (?Parent?), Iora Health, Inc., a Delaware corporation (the ?Company?) and the undersigned holder of Company Capital Stock (together with any of his, her or its Affiliates, the ?Holder?). Each |
|
| June 7, 2021 |
One Medical Announces Agreement to Acquire Iora Health One Medical expands member-based, technology-powered primary care model to every stage of life, and extends into full-risk Medicare reimbursement models Positions One Medical to deliver better health, better care, and lower costs across a combined 28 markets and beyond SAN FRANCISCO ? June 7, 2021 ? 1Life Healthcare, Inc. |
|
| June 7, 2021 |
EX-99.1 2 snowbirdannouncementpressr.htm EX-99.1 One Medical Announces Agreement to Acquire Iora Health One Medical expands member-based, technology-powered primary care model to every stage of life, and extends into full-risk Medicare reimbursement models Positions One Medical to deliver better health, better care, and lower costs across a combined 28 markets and beyond SAN FRANCISCO – June 7, 20 |
|
| June 4, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| May 12, 2021 |
One Medical Announces Results for First Quarter 2021 Exhibit 99.1 One Medical Announces Results for First Quarter 2021 ?First Quarter 2021 Ending Membership Count of 598,000, a 31% Increase Year-Over-Year ?First Quarter 2021 Net Revenue of $121.4 Million, a 54% Increase Year-Over-Year ?Ending First Quarter 2021 Cash and Short-term Marketable Securities of $703.6 Million ?Provides Q2 2021 Guidance SAN FRANCISCO ? May 12, 2021 ? 1Life Healthcare, Inc. |
|
| May 12, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| April 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e) |
|
| April 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| March 17, 2021 |
Form of Common Stock Warrant Agreement and Warrant Certificate Exhibit 4.8 1LIFE HEALTHCARE, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF 1LIFE HEALTHCARE, INC. FORM OF COMMON STOCK WARRANT AGREEMENT THIS COMMON STOCK WARRANT AGREEMENT (this ?Agreement?), dated as of [?], between 1LIFE HEALTHCARE, INC., a Delaware corporation (the ?Company?), and [?], a [corporation] [national banking association] organized and existing under |
|
| March 17, 2021 |
As filed with the U.S. Securities and Exchange Commission on March 17, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 76-0707204 (State or other jurisdiction of Incorporation or organization) (I.R |
|
| March 17, 2021 |
As filed with the Securities and Exchange Commission on March 17, 2021 Registration No. |
|
| March 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39203 1LIFE HEALTHCAR |
|
| March 17, 2021 |
Form of Debt Securities Warrant Agreement and Warrant Certificate EX-4.10 5 onem-ex41010.htm EX-4.10 Exhibit 4.10 1LIFE HEALTHCARE, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF 1LIFE HEALTHCARE, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENT THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between 1Life Healthcare, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national bank |
|
| March 17, 2021 |
Exhibit 4.6 1LIFE HEALTHCARE, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [?], 2021 Debt Securities Table of Contents Page Article 1 DEFINITIONS 1 Section 1.1 Definitions of Terms 1 Article 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.1 Designation and Terms of Securities 4 Section 2.2 Form of Securities and Trustee?s Certificate 6 Sectio |
|
| March 17, 2021 |
Exhibit 4.3 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a description of the common stock, $0.001 par value per share (?Common Stock?) of 1Life Healthcare, Inc. (the ?Company,? ?we,? ?our,? or ?us?), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1 |
|
| March 17, 2021 |
Form of Preferred Stock Warrant Agreement and Warrant Certificate Exhibit 4.9 1LIFE HEALTHCARE, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF 1LIFE HEALTHCARE, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENT THIS PREFERRED STOCK WARRANT AGREEMENT (this ?Agreement?), dated as of [?], between 1LIFE HEALTHCARE, INC., a Delaware corporation (the ?Company?), and [?], a [corporation] [national banking association] organized and exist |
|
| February 25, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2021 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| February 25, 2021 |
One Medical Announces Results for Fourth Quarter and Full Year 2020 EX-99 2 onem-ex9916.htm EX-99.1 Exhibit 99.1 One Medical Announces Results for Fourth Quarter and Full Year 2020 ● 2020 Ending Membership Count of 549,000, a 30% Increase Year-Over-Year ● Fourth Quarter 2020 Net Revenue of $121.8 Million, a 57% Increase Year-Over-Year ● Full Year 2020 Net Revenue of $380.2 Million, a 38% Increase Year-Over-Year ● 2020 Ending Cash and Short-term Marketable Securiti |
|
| February 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 16, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. )* 1Life Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 68269G107 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this |
|
| February 12, 2021 |
Exhibit 99.1 CUSIP NO. 68269G 10 7 13 G AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of 1LIFE HEALTHCARE, INC. Dated: February 12, 2021 dag ventures iv-qp, l.p |
|
| February 12, 2021 |
EX-24 2 d102264dex24.htm EX-24 Exhibit 24 POWER OF ATTORNEY The undersigned understands that, from time to time, the Carlyle Companies (defined below) are required to prepare, execute and file certain federal and state securities laws filings. Know all by these presents, that the undersigned hereby constitutes and appoints each of Jeffrey Ferguson, Jeremy Anderson, Joanne Cosiol, Anne Frederick, K |
|
| February 12, 2021 |
EX-99 Exhibit 99 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. |
|
| February 12, 2021 |
SC 13G Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* 1Life Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 68269 |
|
| February 12, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* 1LIFE HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 68269G 10 7 (CUSIP Number) December 31, 2020 (Date of Event Which Requi |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: 1Life Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 68269G107 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐ R |
|
| December 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2020 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| November 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| November 10, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2020 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| November 10, 2020 |
One Medical Announces Results for Third Quarter 2020 Exhibit 99.1 One Medical Announces Results for Third Quarter 2020 ? Third Quarter 2020 Ending Membership Count of 511,000, a 29% Increase Year-Over-Year ? Third Quarter 2020 Net Revenue of $101.7 Million, a 46% Increase Year-Over-Year ? Ending Third Quarter 2020 Cash and Short-term Marketable Securities of $682.3 Million ? Provides Q4 2020 and Full Year 2020 Guidance SAN FRANCISCO ? November 10, 2 |
|
| August 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| August 12, 2020 |
One Medical Announces Results for Second Quarter 2020 Exhibit 99.1 One Medical Announces Results for Second Quarter 2020 • Second Quarter 2020 Ending Membership Count of 475,000, a 25% Increase Year-Over-Year • Second Quarter 2020 Net Revenue of $78.0 Million, an 18% Increase Year-Over-Year • Ending Second Quarter 2020 Cash and Short-term Marketable Securities of $664.4 Million • Announces plan to expand into two new markets with health network partn |
|
| August 12, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2020 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission |
|
| June 25, 2020 |
424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) File No. 333-239347 and 333-239420 8,300,000 Shares Common Stock The selling stockholders identified in this prospectus are offering an aggregate of 8,300,000 shares of common stock. We are not selling any shares under this prospectus and will not receive any proceeds from the sale of shares by the selling stockholders. Our common stock is l |
|
| June 24, 2020 |
S-1MEF As filed with the Securities and Exchange Commission on June 24, 2020 Registration No. |
|
| June 22, 2020 |
CORRESP 1LIFE HEALTHCARE, INC. One Embarcadero Center, Suite 1900 San Francisco, CA 94111 June 22, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Chris Edwards RE: 1Life Healthcare, Inc. Registration Statement on Form S-1 File No. 333-239347 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of |
|
| June 22, 2020 |
CORRESP J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 June 22, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Chris Edwards Re: 1Life Healthcare, Inc. Registration Statement on Form S-1 (File No. 333-239347) Request for Acc |
|
| June 22, 2020 |
Form of Underwriting Agreement. EX-1.1 Exhibit 1.1 1LIFE HEALTHCARE, INC. [•] Shares of Common Stock Underwriting Agreement June [•], 2020 J.P. Morgan Securities LLC Morgan Stanley & Co. LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Ladies and Gentlemen: C |
|
| June 22, 2020 |
S-1 Table of Contents As filed with the Securities and Exchange Commission on June 22, 2020 Registration No. |
|
| June 9, 2020 |
Confidential Treatment Requested by 1Life Healthcare, Inc. Pursuant to 17 C.F.R. Section 200.83 As confidentially submitted with the U.S. Securities and Exchange Commission on June 9, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as |
|
| May 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2020 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| May 29, 2020 |
Exhibit 4.1 1LIFE HEALTHCARE, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of May 29, 2020 3.00% Convertible Senior Notes due 2025 TABLE OF CONTENTS Page Article 1 Definitions Section 1.01 . Definitions 1 Section 1.02 . References to Interest 14 Article 2 Issue, Description, Execution, Registration and Exchange of Notes Section 2.01 . Designation and Amount 14 Section 2.0 |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39203 1LIFE HEALTHCARE, INC. |
|
| May 13, 2020 |
One Medical Announces Results for First Quarter 2020 Exhibit 99.1 One Medical Announces Results for First Quarter 2020 ● First Quarter 2020 Net Revenue of $78.8 Million, a 25% Increase Year-Over-Year ● First Quarter 2020 Ending Membership Count of Approximately 455,000, a 25% Increase Year-Over-Year ● Ending First Quarter 2020 Cash and Short-term Marketable Securities Balance of $375.4 million; $2.2 million in debt ● Provides Q2 2020 Guidance SAN FR |
|
| May 13, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2020 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| March 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39203 1LIFE HEALTHCAR |
|
| March 27, 2020 |
Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a description of the common stock, $0.001 par value per share (“Common Stock”) of 1Life Healthcare, Inc. (the “Company,” “we,” “our,” or “us”) , which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange Act of |
|
| March 18, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2020 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| March 18, 2020 |
One Medical Announces Results for Fourth Quarter and Full Year 2019 Exhibit 99.1 One Medical Announces Results for Fourth Quarter and Full Year 2019 • Fourth Quarter 2019 Net Revenue of $77.4 Million, a 33% Increase Year-Over-Year • Full Year 2019 Net Revenue of $276.3 Million, a 30% Increase Year-Over-Year • 2019 Ending Membership Count of Approximately 422 Thousand, a 22% Increase Year-Over-Year • Provides Q1 2020 Guidance • Announces Plan to Expand into Austin |
|
| February 4, 2020 |
S-8 As filed with the U.S. Securities and Exchange Commission on February 4, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 76-0707204 (State or other jurisdiction of Incorporation or organization |
|
| February 4, 2020 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2020 1LIFE HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39203 76-0707204 (State or Other Jurisdiction of Incorporation) (Commis |
|
| February 4, 2020 |
Amended and Restated Certificate of Incorporation of the Registrant EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF 1LIFE HEALTHCARE, INC. Amir Dan Rubin hereby certifies that: ONE: The original name of this corporation is 1Life Healthcare, Inc. and the date of filing the original Certificate of Incorporation of this corporation with the Secretary of State of the State of Delaware was July 25, 2002. TWO: He is the duly elected and acting Pr |
|
| February 3, 2020 |
424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-235792 Common Stock 17,500,000 Shares This is the initial public offering of shares of common stock of 1Life Healthcare, Inc. We are offering 17,500,000 shares of our common stock. Prior to this offering, there was no public market for our common stock. The initial public offering price is $14.00 per share. Our common st |
|
| January 28, 2020 |
ONEM / 1Life Healthcare, Inc. CORRESP - - CORRESP J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 January 28, 2020 VIA EMAIL AND EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: William Mastrianna Celeste Murphy Tracey Houser Mary Mast RE: 1Life Healthcare, Inc. Registration St |
|
| January 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 1LIFE HEALTHCARE, INC. |
|
| January 28, 2020 |
ONEM / 1Life Healthcare, Inc. CORRESP - - CORRESP 1LIFE HEALTHCARE, INC. One Embarcadero Center, Suite 1900 San Francisco, CA 94111 January 28, 2020 VIA EMAIL AND EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: William Mastrianna Celeste Murphy Tracey Houser Mary Mast RE: 1Life Healthcare, Inc. Registration Statement on Form S-1 File No. 333-235792 Ladies and Ge |
|
| January 21, 2020 |
Exhibit 10.17 1LIFE HEALTHCARE, INC. AGREEMENT for AMIR DAN RUBIN This Agreement (this ?Agreement?), is made and entered into as of June 27, 2017 by and between Amir Dan Rubin (?Executive?) and 1Life Healthcare, Inc. (the ?Company?). 1. Employment by the Company. 1.1 Position. Executive shall serve as the President and Chief Executive Officer of the Company, reporting to the Board of Directors of |
|
| January 21, 2020 |
Form of Underwriting Agreement. Exhibit 1.1 1LIFE HEALTHCARE, INC. [ ] Shares of Common Stock Underwriting Agreement January [ ], 2020 J.P. Morgan Securities LLC Morgan Stanley & Co. LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Ladies and Gentlemen: 1Life |
|
| January 21, 2020 |
Exhibit 10.7 1LIFE HEALTHCARE, INC. 2020 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT As reflected by your Stock Option Grant Notice (?Grant Notice?) 1Life Healthcare, Inc. (the ?Company?) has granted you an option under its 2020 Equity Incentive Plan (the ?Plan?) to purchase a number of shares of Common Stock at the exercise price indicated in your Grant Notice (the ?Option?). Capitalized terms n |
|
| January 21, 2020 |
Form of common stock certificate of the Registrant. Exhibit 4.1 OM INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CUSIP 68269G 10 7 SEE REVERSE FOR CERTAIN DEFINITIONS AND LEGENDS This certifies that SPECIMEN is the record holder of FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $0.001 PAR VALUE PER SHARE, OF 1LIFE HEALTHCARE, INC. transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of th |
|
| January 21, 2020 |
Exhibit 10.1 Execution Version 1LIFE HEALTHCARE, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT TABLE OF CONTENTS PAGE SECTION 1. GENERAL 1 1.1 Amendment and Restatement of Prior Agreement 1 1.2 Definitions 2 SECTION 2. RESTRICTIONS ON TRANSFER; REGISTRATION 4 2.1 Restrictions on Transfer 4 2.2 Demand Registration 6 2.3 Piggyback Registrations 7 2.4 Form S-3 Registration; Underwritten Shelf T |
|
| January 21, 2020 |
Exhibit 10.6 1LIFE HEALTHCARE, INC. 2020 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2019 APPROVED BY THE STOCKHOLDERS: JANUARY 15, 2020 TABLE OF CONTENTS Page 1. GENERAL 1 2. SHARES SUBJECT TO THE PLAN 1 3. ELIGIBILITY AND LIMITATIONS 2 4. OPTIONS AND STOCK APPRECIATION RIGHTS 3 5. AWARDS OTHER THAN OPTIONS AND STOCK APPRECIATION RIGHTS 6 6. ADJUSTMENTS UPON CHANGES IN |
|
| January 21, 2020 |
Exhibit 10.11 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) dated as of [ ], 2020, is made by and between 1LIFE HEALTHCARE, INC., a Delaware corporation (the ?Company? or ?One Medical?), and (?Indemnitee?). RECITALS A. The Company desires to attract and retain the services of highly qualified individuals as directors, officers, employees and agents. B. The Company?s amended and r |
|
| January 21, 2020 |
As filed with the U.S. Securities and Exchange Commission on January 21, 2020. Table of Contents As filed with the U.S. Securities and Exchange Commission on January 21, 2020. Registration No. 333-235792 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 8011 76-0707204 (State or other |
|
| January 21, 2020 |
Amended and Restated Bylaws of 1Life Healthcare, Inc. Exhibit 3.4 AMENDED AND RESTATED BYLAWS OF 1LIFE HEALTHCARE, INC. (A DELAWARE CORPORATION) TABLE OF CONTENTS PAGE ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II CORPORATE SEAL 1 Section 3. Corporate Seal 1 ARTICLE III STOCKHOLDERS? MEETINGS 1 Section 4. Place of Meetings 1 Section 5. Annual Meetings 1 Section 6. Special Meetings 5 Section 7. Notice of Meet |
|
| January 21, 2020 |
Exhibit 10.8 [Employee?Mandatory Sell to Cover] 1LIFE HEALTHCARE, INC. RSU AWARD GRANT NOTICE (2020 Equity Incentive Plan) 1Life Healthcare, Inc. (the ?Company?) has awarded to you (the ?Participant?) the number of restricted stock units specified and on the terms set forth below in consideration of your services (the ?RSU Award?). Your RSU Award is subject to all of the terms and conditions as se |
|
| January 21, 2020 |
Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF 1LIFE HEALTHCARE, INC. Amir Dan Rubin hereby certifies that: ONE: The original name of this corporation is 1Life Healthcare, Inc. and the date of filing the original Certificate of Incorporation of this corporation with the Secretary of State of the State of Delaware was July 25, 2002. TWO: He is the duly elected and acting President |
|
| January 21, 2020 |
1Life Healthcare, Inc. Executive Severance and Change in Control Plan. Exhibit 10.26 1LIFE HEALTHCARE, INC. EXECUTIVE SEVERANCE AND CHANGE IN CONTROL PLAN ADOPTED: January 17, 2020 Executive Group Executive Severance Benefits in connection with a Separation from Service Within Twelve Months Following a Change in Control All Officers other than CEO ???12 months base salary ???Full performance-based bonus at target ???12 months COBRA benefits continuation ???Double Tri |
|
| January 21, 2020 |
2020 Employee Stock Purchase Plan. Exhibit 10.9 1LIFE HEALTHCARE, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: SEPTEMBER 19, 2019 APPROVED BY THE STOCKHOLDERS: JANUARY 15, 2020 1. GENERAL; PURPOSE. (a) The Plan provides a means by which Eligible Employees of the Company and certain designated Related Corporations may be given an opportunity to purchase shares of Common Stock. The Plan permits the Compan |
|
| January 21, 2020 |
2017 Equity Incentive Plan, as amended. Exhibit 10.4 1LIFE HEALTHCARE, INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 9, 2017 APPROVED BY THE STOCKHOLDERS: February 17, 2017 ADOPTED BY THE BOARD OF DIRECTORS: September 14, 2017 APPROVED BY THE STOCKHOLDERS: November 20, 2017 AMENDED BY THE BOARD OF DIRECTORS: November 21, 2019 APPROVED BY THE STOCKHOLDERS: January 15, 2020 TERMINATION DATE: February 8, 2027 |
|
| January 8, 2020 |
ONEM / 1Life Healthcare, Inc. CORRESP - - CORRESP Matthew B. Hemington +1 650 843 5062 [email protected] *FOIA Confidential Treatment Request* Confidential Treatment Requested by 1Life Healthcare, Inc. in connection with its Registration Statement on Form S-1 filed on January 3, 2020 VIA EDGAR AND COURIER January 8, 2020 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Mail Stop 4546 Washing |
|
| January 3, 2020 |
Exhibit 10.20 1LIFE, INC. PROVIDER STOCK OPTION PROGRAM & ADVISORY SERVICES AGREEMENT Congratulations! You have been selected to participate in the 1Life Healthcare, Inc. (?Company?) Stock Option Plan through this Provider Stock Option Program and Advisory Services Agreement (?Agreement?). This Provider Stock Option Program has been designed to enable the Company to compensate certain medical serv |
|
| January 3, 2020 |
Warrant issued to Silicon Valley Bank, dated January 30, 2013. Exhibit 10.14 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, |
|
| January 3, 2020 |
Exhibit 10.24 SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this ?Agreement?) dated as of January 26, 2015 (the ?Effective Date?) between SILICON VALLEY BANK, a California corporation (?Bank?), and 1LIFE HEALTHCARE, INC., a Delaware corporation (?Borrower?), provides the terms on which Bank shall lend to Borrower and Borrower |
|
| January 3, 2020 |
Inbound Services Agreement, dated August 18, 2017, by and between the Registrant and Google Inc. Exhibit 10.25 Certain information contained in this document, identified by [***], has been redacted because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed. GOOGLE INBOUND SERVICES AGREEMENT This Inbound Services Agreement (?ISA?) is effective as of the Effective Date and is entered into by and among Google, 1Life, and One Medical G |
|
| January 3, 2020 |
2017 Equity Incentive Plan, as amended. Exhibit 10.4 1LIFE HEALTHCARE, INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 9, 2017 APPROVED BY THE STOCKHOLDERS: February 17, 2017 ADOPTED BY THE BOARD OF DIRECTORS: September 14, 2017 APPROVED BY THE STOCKHOLDERS: November 20, 2017 TERMINATION DATE: February 8, 2027 1. GENERAL. (a) Successor to and Continuation of Prior Plan. The Plan is intended as the successor t |
|
| January 3, 2020 |
Exhibit 10.23 ADMINISTRATIVE SERVICES AGREEMENT by and between 1LIFE HEALTHCARE, INC. and [ONE MEDICAL GROUP] ADMINISTRATIVE SERVICES AGREEMENT THIS ADMINISTRATIVE SERVICES AGREEMENT (?Agreement?) is entered into by and between 1Life Healthcare, Inc., a Delaware corporation (?Administrator?) and [One Medical Group, a [ ] professional corporation] (?Group?) shall govern and be deemed to be effectiv |
|
| January 3, 2020 |
Exhibit 10.19 PHYSICIAN EMPLOYMENT AGREEMENT by and between Apollo Medical Group, Inc. (?Group?) and Andrew Diamond, MD. (?Physician?) PHYSICIAN EMPLOYMENT AGREEMENT THIS PHYSICIAN EMPLOYMENT AGREEMENT (?Agreement?) is entered into as of August 1, 2007 (the ?Execution Date?), by and between Apollo Medical Group DBA Metropolitan Medical Group, a California professional medical corporation (?Group?) |
|
| January 3, 2020 |
Exhibit 10.1 1LIFE HEALTHCARE, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT TABLE OF CONTENTS PAGE SECTION 1. GENERAL 2 1.1 Amendment and Restatement of Prior Agreement 2 1.2 Definitions 2 SECTION 2. RESTRICTIONS ON TRANSFER; REGISTRATION 4 2.1 Restrictions on Transfer 4 2.2 Demand Registration 6 2.3 Piggyback Registrations 7 2.4 Form S-3 Registration 9 2.5 Expenses of Registration 10 2.6 O |
|
| January 3, 2020 |
Amended and Restated Bylaws of the Registrant, as currently in effect. Exhibit 3.3 AMENDED AND RESTATED BYLAWS OF 1LIFE HEALTHCARE, INC. (A DELAWARE CORPORATION) TABLE OF CONTENTS PAGE ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II CORPORATE SEAL 1 Section 3. Corporate Seal 1 ARTICLE III STOCKHOLDERS? MEETINGS 1 Section 4. Place of Meetings 1 Section 5. Annual Meeting 2 Section 6. Special Meetings 4 Section 7. Notice of Meeti |
|
| January 3, 2020 |
Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF 1LIFE HEALTHCARE, INC. Amir Dan Rubin hereby certifies that: ONE: The original name of this company is 1Life Healthcare, Inc. and the date of filing the original Certificate of Incorporation of this company with the Secretary of State of the State of Delaware was July 25, 2002. TWO: He is the duly elected and acting President and Chi |
|
| January 3, 2020 |
2007 Equity Incentive Plan, as amended. Exhibit 10.2 1LIFE HEALTHCARE, INC. AMENDED 2007 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: APRIL 24, 2007 APPROVED BY THE STOCKHOLDERS: MAY 4, 2007; AMENDED BY THE BOARD OF DIRECTORS: JULY 2, 2007 APPROVED BY THE STOCKHOLDERS: JULY 2, 2007 AMENDED BY THE BOARD OF DIRECTORS: NOVEMBER 5, 2008 APPROVED BY THE STOCKHOLDERS: NOVEMBER 5, 2008 AMENDED BY THE BOARD OF DIRECTORS: SEPTEMBER 4 |
|
| January 3, 2020 |
Form of Warrant to purchase Common Stock. Exhibit 10.16 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 1LIFE HEALTHC |
|
| January 3, 2020 |
Employment Agreement, dated June 27, 2017, by and between the Registrant and Amir Dan Rubin. Exhibit 10.17 1LIFE HEALTHCARE, INC. AGREEMENT for AMIR DAN RUBIN This Agreement (this ?Agreement?), is made and entered into as of June 27, 2017 by and between Amir Dan Rubin (?Executive?) and 1Life Healthcare, Inc. (the ?Company?). 1. Employment by the Company. 1.1 Position. Executive shall serve as the President and Chief Executive Officer of the Company, reporting to the Board of Directors of |
|
| January 3, 2020 |
Exhibit 10.3 1LIFE HEALTHCARE, INC. STOCK OPTION GRANT NOTICE (2007 EQUITY INCENTIVE PLAN) 1Life Healthcare, Inc. (the ?Company?), pursuant to its 2007 Equity Incentive Plan (the ?Plan?), hereby grants to Optionholder an option to purchase the number of shares of the Company?s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth herein and in the Opt |
|
| January 3, 2020 |
Offer Letter, dated October 16, 2015, by and between the Registrant and Lisa A. Mango. Exhibit 10.28 October 16, 2015 To: Lisa Mango Dear Lisa: Congratulations! We are thrilled to offer you a position as Assistant General Counsel at lLife HealthCare, Inc. (the company behind the One Medical brand). My colleagues and I are confident you will flourish here, and know you?ll help advance our shared mission of transforming healthcare. This is a full time position, reporting to Beth Frens |
|
| January 3, 2020 |
Offer Letter, dated February 14, 2019, by and between the Registrant and Bjorn B. Thaler. Exhibit 10.27 February 14, 2019 To: Bjorn Thaler Dear Bjorn, Congratulations! We are thrilled to offer you a position as Chief Financial Officer at 1Life HealthCare, Inc. (the company behind the One Medical brand). My colleagues and I are confident you will flourish here, and know you?ll help advance our shared mission of transforming healthcare. This is a full-time position based in San Francisco |
|
| January 3, 2020 |
Exhibit 10.21 OFFICE LEASE ONE EMBARCADERO CENTER ONE EMBARCADERO CENTER VENTURE, a California general partnership, as Landlord, and 1LIFE HEALTHCARE, INC. a Delaware corporation, as Tenant. [ONE EMBARCADERO CENTER] [1Life Healthcare, Inc.] [AMLGM&N] TABLE OF CONTENTS Page ARTICLE 1 PREMISES, BUILDING, PROJECT, AND COMMON AREAS 4 ARTICLE 2 LEASE TERM 7 ARTICLE 3 BASE RENT 12 ARTICLE 4 ADDITIONAL R |
|
| January 3, 2020 |
Executive Annual Incentive Plan. Exhibit 10.10 1LIFE HEALTHCARE, INC. EXECUTIVE ANNUAL INCENTIVE PLAN 1. PURPOSE The Executive Annual Incentive Plan (the ?Plan?) is designed to provide cash-based incentive compensation to individuals who make important contributions to the success of 1Life Healthcare, Inc. (the ?Company?). The Plan is intended to provide individuals with incentives and rewards for outstanding performance and to e |
|
| January 3, 2020 |
Warrant issued to Silicon Valley Bank, dated February 26, 2010. Exhibit 10.12 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, |
|
| January 3, 2020 |
Exhibit 10.5 1LIFE HEALTHCARE, INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) 1LIFE HEALTHCARE, INC. (the ?Company?), pursuant to its 2017 Equity Incentive Plan (the ?Plan?), hereby grants to Optionholder an option to purchase the number of shares of the Company?s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth in this notice, in th |
|
| January 3, 2020 |
ONEM / 1Life Healthcare, Inc. CORRESP - - CORRESP Matthew B. Hemington +1 650 843 5062 [email protected] VIA EDGAR AND COURIER January 3, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C., 20549 Attn: Folake Ayoola Celeste Murphy Tracey Houser Mary Mast Re: 1Life Healthcare, Inc. Amended Draft Registration Statement on Form S-1 Submitted November 26, 2019 CIK No. |
|
| January 3, 2020 |
Offer Letter, dated March 7, 2014, by and between the Registrant and Kimber D. Lockhart. Exhibit 10.18 Kimber Lockhart [email protected] March 7, 2014 Dear Kimber, I am pleased to offer you the position of Vice President, Engineering reporting to me. My colleagues and I are excited about the prospect of you joining. You will have significant positive impact as you build up the product technology capabilities that will innovate healthcare. Your start date will be March 19, 2014 |
|
| January 3, 2020 |
Exhibit 10.22 ONE EMBARCADERO CENTER 1LIFE HEALTHCARE, INC. FIRST AMENDMENT TO OFFICE LEASE This FIRST AMENDMENT TO OFFICE LEASE, (the ?Amendment?) is made and entered into as of the 17 day of June, 2019 (?Effective Date?) by and between One Embarcadero Center Venture, a California general partnership (?Landlord?), and 1LIFE HEALTHCARE, INC., a Delaware corporation (?Tenant?). R E C I T A L S: A. |
|
| January 3, 2020 |
Table of Contents As filed with the U.S. Securities and Exchange Commission on January 3, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 8011 76-0707204 (State or other jurisdiction of incorporat |
|
| January 3, 2020 |
Warrant issued to Silicon Valley Bank, dated January 26, 2015. Exhibit 10.15 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, |
|
| January 3, 2020 |
Warrant issued to Silicon Valley Bank, dated June 28, 2011. Exhibit 10.13 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, |
|
| November 26, 2019 |
ONEM / 1Life Healthcare, Inc. DRSLTR - - DRSLTR Matthew B. Hemington +1 650 843 5062 [email protected] VIA EDGAR AND COURIER November 26, 2019 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington D.C., 20549 Attn: Folake Ayoola Celeste Murphy Tracey Houser Mary Mast Re: 1Life Healthcare, Inc. Draft Registration Statement on Form S-1 Submitted October 18, 2019 CIK No. 00014041 |
|
| November 26, 2019 |
GOOGLE INBOUND SERVICES AGREEMENT Exhibit 10.25 Certain information contained in this document, identified by [***], has been redacted because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed. GOOGLE INBOUND SERVICES AGREEMENT This Inbound Services Agreement (?ISA?) is effective as of the Effective Date and is entered into by and among Google, 1Life, and One Medical G |
|
| November 26, 2019 |
As confidentially submitted to the U.S. Securities and Exchange Commission on November 26, 2019. Table of Contents As confidentially submitted to the U.S. Securities and Exchange Commission on November 26, 2019. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 8011 76-0707204 (State or other jurisdi |
|
| October 18, 2019 |
AMENDED AND RESTATED 1LIFE HEALTHCARE, INC. (A DELAWARE CORPORATION) Exhibit 3.3 AMENDED AND RESTATED BYLAWS OF 1LIFE HEALTHCARE, INC. (A DELAWARE CORPORATION) TABLE OF CONTENTS PAGE ARTICLE I OFFICES 1 Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II CORPORATE SEAL 1 Section 3. Corporate Seal 1 ARTICLE III STOCKHOLDERS? MEETINGS 1 Section 4. Place of Meetings 1 Section 5. Annual Meeting 2 Section 6. Special Meetings 4 Section 7. Notice of Meeti |
|
| October 18, 2019 |
Exhibit 10.16 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 1LIFE HEALTHC |
|
| October 18, 2019 |
Exhibit 10.19 PHYSICIAN EMPLOYMENT AGREEMENT by and between Apollo Medical Group, Inc. (?Group?) and Andrew Diamond, MD. (?Physician?) PHYSICIAN EMPLOYMENT AGREEMENT THIS PHYSICIAN EMPLOYMENT AGREEMENT (?Agreement?) is entered into as of August 1, 2007 (the ?Execution Date?), by and between Apollo Medical Group DBA Metropolitan Medical Group, a California professional medical corporation (?Group?) |
|
| October 18, 2019 |
ONE EMBARCADERO CENTER 1LIFE HEALTHCARE, INC. FIRST AMENDMENT TO OFFICE LEASE Exhibit 10.22 ONE EMBARCADERO CENTER 1LIFE HEALTHCARE, INC. FIRST AMENDMENT TO OFFICE LEASE This FIRST AMENDMENT TO OFFICE LEASE, (the ?Amendment?) is made and entered into as of the 17 day of June, 2019 (?Effective Date?) by and between One Embarcadero Center Venture, a California general partnership (?Landlord?), and 1LIFE HEALTHCARE, INC., a Delaware corporation (?Tenant?). R E C I T A L S: A. |
|
| October 18, 2019 |
1LIFE HEALTHCARE, INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) Exhibit 10.5 1LIFE HEALTHCARE, INC. STOCK OPTION GRANT NOTICE (2017 EQUITY INCENTIVE PLAN) 1LIFE HEALTHCARE, INC. (the ?Company?), pursuant to its 2017 Equity Incentive Plan (the ?Plan?), hereby grants to Optionholder an option to purchase the number of shares of the Company?s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth in this notice, in th |
|
| October 18, 2019 |
Exhibit 10.14 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, |
|
| October 18, 2019 |
Exhibit 10.13 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, |
|
| October 18, 2019 |
As confidentially submitted to the U.S. Securities and Exchange Commission on October 18, 2019. Table of Contents As confidentially submitted to the U.S. Securities and Exchange Commission on October 18, 2019. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 1LIFE HEALTHCARE, INC. (Exact name of Registrant as specified in its charter) Delaware 8011 76-0707204 (State or other jurisdic |
|
| October 18, 2019 |
Exhibit 10.21 OFFICE LEASE ONE EMBARCADERO CENTER ONE EMBARCADERO CENTER VENTURE, a California general partnership, as Landlord, and 1LIFE HEALTHCARE, INC. a Delaware corporation, as Tenant. [ONE EMBARCADERO CENTER] [1Life Healthcare, Inc.] [AMLGM&N] TABLE OF CONTENTS Page ARTICLE 1 PREMISES, BUILDING, PROJECT, AND COMMON AREAS 4 ARTICLE 2 LEASE TERM 7 ARTICLE 3 BASE RENT 12 ARTICLE 4 ADDITIONAL R |
|
| October 18, 2019 |
Exhibit 10.4 1LIFE HEALTHCARE, INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: February 9, 2017 APPROVED BY THE STOCKHOLDERS: February 17, 2017 ADOPTED BY THE BOARD OF DIRECTORS: September 14, 2017 APPROVED BY THE STOCKHOLDERS: November 20, 2017 TERMINATION DATE: February 8, 2027 1. GENERAL. (a) Successor to and Continuation of Prior Plan. The Plan is intended as the successor t |
|
| October 18, 2019 |
1LIFE HEALTHCARE, INC. AMIR DAN RUBIN Exhibit 10.17 1LIFE HEALTHCARE, INC. AGREEMENT for AMIR DAN RUBIN This Agreement (this ?Agreement?), is made and entered into as of June 27, 2017 by and between Amir Dan Rubin (?Executive?) and 1Life Healthcare, Inc. (the ?Company?). 1. Employment by the Company. 1.1 Position. Executive shall serve as the President and Chief Executive Officer of the Company, reporting to the Board of Directors of |
|
| October 18, 2019 |
1LIFE HEALTHCARE, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT Exhibit 10.1 1LIFE HEALTHCARE, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT TABLE OF CONTENTS PAGE SECTION 1. GENERAL 2 1.1 Amendment and Restatement of Prior Agreement 2 1.2 Definitions 2 SECTION 2. RESTRICTIONS ON TRANSFER; REGISTRATION 4 2.1 Restrictions on Transfer 4 2.2 Demand Registration 6 2.3 Piggyback Registrations 7 2.4 Form S-3 Registration 9 2.5 Expenses of Registration 10 2.6 O |
|
| October 18, 2019 |
Exhibit 10.12 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, |
|
| October 18, 2019 |
SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT Exhibit 10.24 SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this ?Agreement?) dated as of January 26, 2015 (the ?Effective Date?) between SILICON VALLEY BANK, a California corporation (?Bank?), and 1LIFE HEALTHCARE, INC., a Delaware corporation (?Borrower?), provides the terms on which Bank shall lend to Borrower and Borrower |
|
| October 18, 2019 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION 1LIFE HEALTHCARE, INC. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF 1LIFE HEALTHCARE, INC. Amir Dan Rubin hereby certifies that: ONE: The original name of this company is 1Life Healthcare, Inc. and the date of filing the original Certificate of Incorporation of this company with the Secretary of State of the State of Delaware was July 25, 2002. TWO: He is the duly elected and acting President and Chi |
|
| October 18, 2019 |
1LIFE HEALTHCARE, INC. STOCK OPTION GRANT NOTICE (2007 EQUITY INCENTIVE PLAN) Exhibit 10.3 1LIFE HEALTHCARE, INC. STOCK OPTION GRANT NOTICE (2007 EQUITY INCENTIVE PLAN) 1Life Healthcare, Inc. (the ?Company?), pursuant to its 2007 Equity Incentive Plan (the ?Plan?), hereby grants to Optionholder an option to purchase the number of shares of the Company?s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth herein and in the Opt |
|
| October 18, 2019 |
1LIFE HEALTHCARE, INC. EXECUTIVE ANNUAL INCENTIVE PLAN Exhibit 10.10 1LIFE HEALTHCARE, INC. EXECUTIVE ANNUAL INCENTIVE PLAN 1. PURPOSE The Executive Annual Incentive Plan (the ?Plan?) is designed to provide cash-based incentive compensation to individuals who make important contributions to the success of 1Life Healthcare, Inc. (the ?Company?). The Plan is intended to provide individuals with incentives and rewards for outstanding performance and to e |
|
| October 18, 2019 |
ADMINISTRATIVE SERVICES AGREEMENT by and between 1LIFE HEALTHCARE, INC. [ONE MEDICAL GROUP] Exhibit 10.23 ADMINISTRATIVE SERVICES AGREEMENT by and between 1LIFE HEALTHCARE, INC. and [ONE MEDICAL GROUP] ADMINISTRATIVE SERVICES AGREEMENT THIS ADMINISTRATIVE SERVICES AGREEMENT (?Agreement?) is entered into by and between 1Life Healthcare, Inc., a Delaware corporation (?Administrator?) and [One Medical Group, a [ ] professional corporation] (?Group?) shall govern and be deemed to be effectiv |
|
| October 18, 2019 |
Exhibit 10.2 1LIFE HEALTHCARE, INC. AMENDED 2007 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: APRIL 24, 2007 APPROVED BY THE STOCKHOLDERS: MAY 4, 2007; AMENDED BY THE BOARD OF DIRECTORS: JULY 2, 2007 APPROVED BY THE STOCKHOLDERS: JULY 2, 2007 AMENDED BY THE BOARD OF DIRECTORS: NOVEMBER 5, 2008 APPROVED BY THE STOCKHOLDERS: NOVEMBER 5, 2008 AMENDED BY THE BOARD OF DIRECTORS: SEPTEMBER 4 |
|
| October 18, 2019 |
1LIFE, INC. PROVIDER STOCK OPTION PROGRAM & ADVISORY SERVICES AGREEMENT Exhibit 10.20 1LIFE, INC. PROVIDER STOCK OPTION PROGRAM & ADVISORY SERVICES AGREEMENT Congratulations! You have been selected to participate in the 1Life Healthcare, Inc. (?Company?) Stock Option Plan through this Provider Stock Option Program and Advisory Services Agreement (?Agreement?). This Provider Stock Option Program has been designed to enable the Company to compensate certain medical serv |
|
| October 18, 2019 |
Exhibit 10.15 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, |
|
| October 18, 2019 |
Exhibit 10.18 Kimber Lockhart [email protected] March 7, 2014 Dear Kimber, I am pleased to offer you the position of Vice President, Engineering reporting to me. My colleagues and I are excited about the prospect of you joining. You will have significant positive impact as you build up the product technology capabilities that will innovate healthcare. Your start date will be March 19, 2014 |
